Drug intelligence / Profile preview

Travelan

Development stage
Unknown
Lead developer
Immuron
Modality
Antibody-Based Therapeutics
Administration
Oral
01

Overview

Travelan is a hyperimmune bovine colostrum (HBC) product developed by Immuron Ltd. for the prevention of traveler's diarrhea. The active ingredient, IMM-124E, is a polyclonal antibody preparation harvested from the colostrum of dairy cows that have been immunized with a vaccine containing multiple strains of enterotoxigenic Escherichia coli (ETEC). When taken orally, these antibodies provide passive immunity by binding to bacterial surface antigens and toxins within the gastrointestinal tract, thereby neutralizing the pathogens and preventing their attachment to the intestinal mucosa. Although primarily designed to target ETEC, the antibodies in Travelan have demonstrated cross-reactivity against other major enteric pathogens, including Shigella, Salmonella, and Campylobacter species. The product is commercially available as a dietary supplement in tablet form in the United States, Australia, and Canada.

Brand names
Travelan
Other names
hyperimmune bovine colostrumHBChyperimmune bovine colostrum powder

Beyond the preview

Go deeper on Travelan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Travelan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call